SpineGuard announced on Thursday that it had arranged bond financing worth 7.5 million euros, which will enable it to extend its cash flow horizon to the end of 2026.

The 'medtech' company, which specializes in real-time surgical guidance for bone implant placement, said it had obtained the funds from Nice & Green, an investment company that has been a partner since 2017.

The funds will give the company the visibility and room to maneuver it needs to expand its commercial deployment, particularly in the United States.

SpineGuard's share price fell by more than 18% following the announcement at midday on Thursday.

Copyright (c) 2023 CercleFinance.com. All rights reserved.